GoodRx Holdings, Inc. (GDRX) Free cash flow 2018–2025
GoodRx Holdings, Inc. (GDRX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$164.4MFY2025 · since FY2018: $44.4M → $164.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $164.4M | -10.0% |
| FY2024 | $182.7M | +33.1% |
| FY2023 | $137.2M | -3.9% |
| FY2022 | $142.8M | -18.0% |
| FY2021 | $174.2M | +57.2% |
| FY2020 | $110.8M | +35.3% |
| FY2019 | $81.9M | +84.2% |
| FY2018 | $44.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice